BR112017005518A2 - ?derivados de 7-(morfolinil)-2-(n-piperazinil) metil-tieno [2, 3-c] piridina como drogas anticancerígenas? - Google Patents

?derivados de 7-(morfolinil)-2-(n-piperazinil) metil-tieno [2, 3-c] piridina como drogas anticancerígenas?

Info

Publication number
BR112017005518A2
BR112017005518A2 BR112017005518A BR112017005518A BR112017005518A2 BR 112017005518 A2 BR112017005518 A2 BR 112017005518A2 BR 112017005518 A BR112017005518 A BR 112017005518A BR 112017005518 A BR112017005518 A BR 112017005518A BR 112017005518 A2 BR112017005518 A2 BR 112017005518A2
Authority
BR
Brazil
Prior art keywords
methylthieno
piperazinyl
morpholinyl
anticancer drugs
pyridine derivatives
Prior art date
Application number
BR112017005518A
Other languages
English (en)
Other versions
BR112017005518B1 (pt
Inventor
Prasad Konakanchi Durga
Rama Rao RAVI Janaki
Satya Bhujanga Rao Adibhatla Kali
Viswa Venkata Pavan Kumar MADDULA Lakshmana
Vasanta Srinivasu Vuppalapati Naga
Reddy Muddasani Pulla
Krishna PILLI Rama
Kumar Thoota Sandeep
Krishna Murthy KONDURI Srinivasa
Rao Pula Subba
Chowdary Nannapaneni Venkaiah
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Publication of BR112017005518A2 publication Critical patent/BR112017005518A2/pt
Publication of BR112017005518B1 publication Critical patent/BR112017005518B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

a presente invenção refere-se a novas séries de 7-(morfolinil) -2- (n-piperazinil) -metil tieno [2,3-c] piridinas substituídas com a seguinte estrutura de fórmula i. em que r1, r2, r3 e r4 são definidos.
BR112017005518-0A 2014-12-11 2014-12-11 Derivados de 7-(morfolinil)-2-(n-piperazinil) metil-tieno [2, 3-c] piridina como drogas anticancerígenas BR112017005518B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2014/000770 WO2016092556A1 (en) 2014-12-11 2014-12-11 7-(morpholinyl)-2-(n-piperazinyl) methyl thieno [2, 3-c] pyridine derivatives as anticancer drugs

Publications (2)

Publication Number Publication Date
BR112017005518A2 true BR112017005518A2 (pt) 2017-12-05
BR112017005518B1 BR112017005518B1 (pt) 2022-11-29

Family

ID=52595387

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005518-0A BR112017005518B1 (pt) 2014-12-11 2014-12-11 Derivados de 7-(morfolinil)-2-(n-piperazinil) metil-tieno [2, 3-c] piridina como drogas anticancerígenas

Country Status (31)

Country Link
US (1) US10106554B2 (pt)
EP (1) EP3230289B1 (pt)
JP (1) JP6454419B2 (pt)
KR (1) KR102328921B1 (pt)
CN (1) CN107074873B (pt)
AP (1) AP2017009749A0 (pt)
AU (1) AU2014413483B2 (pt)
BR (1) BR112017005518B1 (pt)
CA (1) CA2959980C (pt)
CO (1) CO2017002266A2 (pt)
CY (1) CY1122080T1 (pt)
DK (1) DK3230289T3 (pt)
EA (1) EA036819B1 (pt)
ES (1) ES2750268T3 (pt)
HR (1) HRP20192041T1 (pt)
HU (1) HUE047144T2 (pt)
IL (1) IL252254B (pt)
LT (1) LT3230289T (pt)
MA (1) MA40110B2 (pt)
MX (1) MX2017004782A (pt)
MY (1) MY188946A (pt)
NZ (1) NZ729078A (pt)
PH (1) PH12017500342A1 (pt)
PL (1) PL3230289T3 (pt)
PT (1) PT3230289T (pt)
RS (1) RS59409B1 (pt)
SG (1) SG11201702162PA (pt)
SI (1) SI3230289T1 (pt)
UA (1) UA117318C2 (pt)
WO (1) WO2016092556A1 (pt)
ZA (1) ZA201701036B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220099970A (ko) * 2019-10-11 2022-07-14 인사이트 코포레이션 Cdk2 억제제로서의 이환식 아민
CR20220294A (es) 2019-12-20 2022-08-03 Bayer Ag Tiofenocarboxamidas sustituidas y sus derivados
CA3216161A1 (en) * 2021-04-21 2022-10-27 Amala Kompella Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579526A (en) 1968-11-13 1971-05-18 Research Corp Preparation of thienopyridines
FR2411838A1 (fr) 1977-12-19 1979-07-13 Parcor Nouveaux derives des thieno (2-3-c) et (3,2-c) pyridines, leurs procede de preparation et leur application therapeutique
US4839365A (en) 1987-05-19 1989-06-13 Shinogi & Co., Ltd. Thienopyridine derivatives useful in treating gastric ulcers
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
EP1181296A1 (en) 1999-06-03 2002-02-27 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
EP1753428A4 (en) * 2004-05-14 2010-09-15 Abbott Lab INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
EP2032582A1 (en) * 2006-04-26 2009-03-11 F.Hoffmann-La Roche Ag Pyrimidine derivatives as pi3k inhibitors
GB0608264D0 (en) * 2006-04-26 2006-06-07 Piramed Ltd Pharmaceutical compounds
CN101939006B (zh) * 2007-09-12 2015-09-16 吉宁特有限公司 磷酸肌醇3-激酶抑制剂化合物与化疗剂的联合以及使用方法
GB0723748D0 (en) 2007-12-04 2008-01-16 Ucb Pharma Sa Therapeutic agents
DK2276767T3 (da) 2008-03-31 2014-07-14 Genentech Inc Benzopyran- og benzoxepinforbindelser som pi3k-inhibitorer og anvendelsesfremgangsmåder
JP5452617B2 (ja) * 2009-01-08 2014-03-26 キュリス，インコーポレイテッド 亜鉛結合部分を有するホスホイノシチド３−キナーゼインヒビター
CA2775942A1 (en) 2009-09-29 2011-04-07 Xcovery Holding Company Llc Pi3k (delta) selective inhibitors
CA2787714C (en) 2010-01-22 2019-04-09 Joaquin Pastor Fernandez Inhibitors of pi3 kinase
CA2825028A1 (en) * 2011-02-09 2012-08-16 F. Hoffman-La Roche Ag Heterocyclic compounds as pi3 kinase inhibitors

Also Published As

Publication number Publication date
HRP20192041T1 (hr) 2020-02-07
AU2014413483B2 (en) 2019-07-25
KR20170090434A (ko) 2017-08-07
CN107074873A (zh) 2017-08-18
SI3230289T1 (sl) 2019-10-30
BR112017005518B1 (pt) 2022-11-29
WO2016092556A1 (en) 2016-06-16
NZ729078A (en) 2021-07-30
DK3230289T3 (da) 2019-10-28
ZA201701036B (en) 2019-06-26
MX2017004782A (es) 2017-07-27
PH12017500342A1 (en) 2017-07-17
MA40110A1 (fr) 2017-12-29
AU2014413483A1 (en) 2017-03-09
AP2017009749A0 (en) 2017-02-28
CY1122080T1 (el) 2020-11-25
IL252254B (en) 2019-08-29
JP2017537139A (ja) 2017-12-14
US20170320891A1 (en) 2017-11-09
PL3230289T3 (pl) 2020-03-31
CO2017002266A2 (es) 2017-05-31
PT3230289T (pt) 2019-10-30
CA2959980A1 (en) 2016-06-16
CN107074873B (zh) 2022-01-07
UA117318C2 (uk) 2018-07-10
JP6454419B2 (ja) 2019-01-16
EP3230289B1 (en) 2019-08-14
EA201791294A1 (ru) 2017-11-30
LT3230289T (lt) 2019-10-10
HUE047144T2 (hu) 2020-04-28
MA40110B2 (fr) 2020-12-31
CA2959980C (en) 2023-04-25
RS59409B1 (sr) 2019-11-29
US10106554B2 (en) 2018-10-23
MY188946A (en) 2022-01-14
EA036819B1 (ru) 2020-12-23
KR102328921B1 (ko) 2021-11-19
ES2750268T3 (es) 2020-03-25
SG11201702162PA (en) 2017-04-27
IL252254A0 (en) 2017-07-31
EP3230289A1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
CO2017007663A2 (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
BR112017006305A2 (pt) compostos heteroarila como inibidores de btk e usos dos mesmos
BR112018003343A2 (pt) compostos heteroarila como inibidores de irak e usos dos mesmos
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
BR112018003812A2 (pt) compostos de heteroarila como inibidores de irak e usos dos mesmos
BR112016024414A2 (pt) inibidores de irak e usos dos mesmos
ECSP14008757A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112017014970A2 (pt) macrociclos de piridazinona como inibidores de irak e usos dos mesmos
BR112016015057A2 (pt) Compostos e composições farmacêuticas e respectivos usos
EA201692000A1 (ru) Макроциклические производные пиридина
BR112017023038A2 (pt) imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
BR112017028549A2 (pt) derivados de pirimidina como inibidores de btk e usos dos mesmos
PH12019501178A1 (en) Thiopene derivatives as antiviral agents
BR112017001334A2 (pt) compostos de imidazopiridazina, seu uso e composição farmacêutica que os compreende
EA201491376A1 (ru) Производные 1h-пирроло[2,3-b]пиридина и их применение в качестве ингибиторов киназы
UY36070A (es) Triterpenoides con actividad inhibidora de la maduración de hiv
UY35997A (es) Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
MX2016005437A (es) Derivados de n-(1-hidroxi-3-(pirrolidinil)propan-2-il)pirrolidin-3 -carboxamida como inhibidores de glucosilceramida sintasa.
CY1122080T1 (el) 7-(μορφολινυλ)-2-(n-πιπεραζινυλ) μεθυλοθειαινο [2,3-c]πυριδινης ως αντικαρκινικα φαρμακα
BR112015020834A2 (pt) novos derivados hidroquinolina-2-ona como inibidores de aldosterona sintetase (cyp1 1 b2 ou cyp1 1 b1)
CL2020001073A1 (es) Nuevos derivados macrocíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
BR112017012007A2 (pt) compostos orgânicos
BR112016008704A8 (pt) derivados de indol-urea glucopiranosil-substituídos, composições farmacêuticas, e seus usos
TR201906180T4 (tr) Glikozaminoglikanların karboksilatlı türevleri ve bunların ilaç olarak kullanımı.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/12/2014, OBSERVADAS AS CONDICOES LEGAIS